Trial Details

RECRUITING
Basic Information
Clinical ID c1622
Identifier NCT04779320
Trial Title A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease (CD)
Interventions DRUG: Vedolizumab IV
Participant Information
Sponsor Takeda
City Phoenix
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2022-02-10
Primary Completion Date 2026-05-22
Completion Date 2026-05-22